-

Vertellus Acquires Polyscope Polymers

Addition of Complementary Product Portfolio Expands European Capabilities and Extends Reach into Attractive Coatings and Electronics Markets

INDIANAPOLIS--(BUSINESS WIRE)--Vertellus, a manufacturer of specialty materials for various personal care, performance coatings, polymer additives, healthcare and food & beverage markets, today announced it has acquired Polyscope Polymers B.V. (“Polyscope”), a global leader in specialty additives for coatings, electronics applications and engineering polymers. With the addition of Polyscope’s complementary product portfolio and advanced manufacturing capabilities, Vertellus expands its European production capabilities and extends its reach in high-growth end markets.

Polyscope is a global leader in the development and production of styrene maleic anhydride (SMA®) copolymers necessary for product applications across the electronic, automotive and specialty coatings & ink markets. With its innovative technology and engineering capabilities, Polyscope is well-positioned to capitalize on growth in these expanding markets. Polyscope operates a state-of-the-art production facility strategically located in Geleen, The Netherlands, and serves as a key partner to more than 300 customers across over 35 countries.

John Van Hulle, CEO of Vertellus, said, “Polyscope adds a complementary portfolio of high-quality solutions, a track record of innovation and a world-class global platform in attractive end markets to Vertellus. Together we will serve our customers with a unique product offering and our shared value-driven approach. I am pleased to welcome the Polyscope team to Vertellus.”

Patrick Muezers, Polyscope CEO, said, “Vertellus is the ideal partner to support the company’s next phase of growth and innovation. We will be able to leverage Vertellus’ global resources, capabilities and strong market leadership to better serve our customers and bring our high-quality products to additional customers throughout our markets.”

Thomas Chadwick, Principal at Pritzker Private Capital, added, “This highly strategic acquisition strengthens Vertellus’ global platform and positions the combined company for growth. We look forward to continuing to support the Vertellus and Polyscope teams as they serve customers with innovative, high-quality products and services.”

Indianapolis-based Vertellus is owned by Pritzker Private Capital and management.

About Vertellus

Vertellus is a leading global manufacturer of specialty materials and key ingredients for fundamental consumer necessities. With a growing portfolio of solutions, Vertellus is dedicated to becoming the preferred global supplier of specialty ingredients and innovative materials that enhance quality of life, support health and wellness and enable customers to deliver value-added solutions. Vertellus technology can be found in personal care products, pharmaceuticals, medical devices, nutraceuticals, food & beverages, performance coatings, transportation additives and more. Headquartered in Indianapolis and founded in 1857, Vertellus has more than 1,300 employees across 15 international research and manufacturing facilities. Vertellus is a Responsible Care® company. For more information, visit www.vertellus.com.

About Polyscope

Polyscope is a global leader in the research, development, and production of styrene maleic anhydride (SMA®) copolymers, a vital material for product applications in high-growth electronics, automotive, coatings and inks end markets. The company offers a broad range of SMA® and SMANPMI co- and terpolymers and compounds for engineering plastic and specialty chemical applications under the trade names XIRAN® and XILOY™. Polyscope’s global customer base is supported by production and research & development conducted in Geleen, The Netherlands, and with local compounding, contract manufacturing facilities and sales and marketing support in Europe, North America, and Asia. For more information, see www.polyscope.eu.

About Pritzker Private Capital

Pritzker Private Capital partners with middle-market companies based in North America with leading positions in the manufactured products and services sectors. The firm’s differentiated, long-duration capital base allows for efficient decision-making, broad flexibility with transaction structure and investment horizon, and alignment with all stakeholders. Pritzker Private Capital builds businesses for the long term and is an ideal partner for entrepreneur and family owned companies. Pritzker Private Capital is a signatory to the United Nations Principles for Responsible Investment (PRI). For more information, visit www.ppcpartners.com.

Contacts

Media:
Abernathy MacGregor
Dan Scorpio / Kyla MacLennan
(312) 640-3111 / 646.939.3062
dps@abmac.com / kam@abmac.com

Vertellus


Release Versions

Contacts

Media:
Abernathy MacGregor
Dan Scorpio / Kyla MacLennan
(312) 640-3111 / 646.939.3062
dps@abmac.com / kam@abmac.com

More News From Vertellus

Aurorium Names Faye Freeman Chief Executive Officer

INDIANAPOLIS--(BUSINESS WIRE)--Aurorium, a specialty ingredients manufacturer and materials innovation partner, today announced that Faye Freeman, currently the company’s President, has been appointed Chief Executive Officer. Ms. Freeman, who joined Aurorium in 2019, will succeed John Van Hulle, who will transition to the role of Executive Chairman. “Faye is a fantastic leader with a proven track record of commercial and operational excellence,” said Mr. Van Hulle. “I’ve worked closely with her...

Aurorium Launches Haelium™ Pharmaceutical Solutions

INDIANAPOLIS--(BUSINESS WIRE)--Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions. This new brand reflects Aurorium’s passion for and long-term commitment to healthcare. Built on decades of innovation, the Haelium product line unifies Aurorium as a global leader in pharmaceutical ingredients. Inspired by the Old English word “hælan," which meant “to cure,” “save,” or “make whole,” the Haelium br...

Vertellus To Present Industry-Leading Portfolio of Medical Adhesives and Coatings at MD&M West 2022

INDIANAPOLIS--(BUSINESS WIRE)--Vertellus, a leading global supplier of high-performance solutions to the medical industry, is showcasing its range of Citroflex™ B6 phthalate free plasticizers, Biothane™ adhesives and sealants and PC Technology™-powered hemocompatible surface coatings at leading medical device expo MD&M West in Anaheim, Calif. Vertellus will be located at Booth 1289 at the Anaheim Convention Center from April 12 to April 14. “We look forward to sharing our high-quality speci...
Back to Newsroom